DIAGNOSTIC METHODS FOR DOLICHOSIGMA IN CHILDREN: A CONTEMPORARY REVIEW AND PRACTICAL ALGORITHM
DOI:
https://doi.org/10.55640/Keywords:
dolichosigma; dolichocolon; chronic constipation; contrast enema (contrast irrigography); anorectal manometry; colonic transit; Hirschsprung disease.Abstract
Dolichosigma (elongation and increased mobility of the sigmoid colon) is a common anatomical finding in children with chronic constipation; however, its clinical significance is heterogeneous. In some patients it represents a normal variant, whereas in others it is associated with impaired colonic transit, megarectum/megasigma, fecal impaction, and episodes of subobstruction. The aim of this work is to systematize contemporary diagnostic methods for dolichosigma in children and to propose a practical diagnostic algorithm, emphasizing the need to exclude organic pathology (primarily Hirschsprung disease) and to phenotype constipation (slow-transit constipation vs evacuation dysfunction). Materials and Methods: a narrative review of clinical guidelines (ESPGHAN/NASPGHAN) and current literature (2014–2025), along with an analysis of diagnostic approaches described in local clinical material. Results: key components include clinical assessment according to Rome IV criteria, identification of “red flags,” contrast enema/contrast irrigography for anatomical verification, and functional testing (anorectal manometry, colonic transit studies, and specialized motility diagnostics) in patients with refractory disease. Conclusion: a rational diagnostic strategy for dolichosigma should follow a stepwise approach—from clinical evaluation to targeted instrumental tests—prioritizing minimization of radiation exposure and mandatory exclusion of Hirschsprung disease in young children or in the presence of “red flags.”
Downloads
References
1.Tabbers MM, DiLorenzo C, Berger MY, et al. Evaluation and treatment of functional constipation in infants and children: evidence-based recommendations from ESPGHAN and NASPGHAN. J Pediatr Gastroenterol Nutr. 2014;58:258–274.
2.Kilgore AL, et al. Evaluation and management of pediatric refractory constipation: recommendations from the NASPGHAN Neurogastroenterology and Motility Committee. J Pediatr Gastroenterol Nutr. 2024.
3.Hyams JS, Di Lorenzo C, Saps M, et al. Functional Disorders: Children and Adolescents (Rome IV). Gastroenterology. 2016.
4.Mulhem E, Khondoker F. Constipation in children and adolescents: evaluation and treatment. Am Fam Physician. 2022;105(5):469–477.
5.Raahave D, et al. Dolichocolon revisited: an inborn anatomic variant with redundancies causing constipation and volvulus. World J Gastrointest Surg. 2018;10(2):6–12.
6.Seguritan R, et al. Redundant: A case of complicated dolichocolon in a neonate. J Surg Case Rep. 2019.
7.Simon D, et al. Dolichocolon in pediatric gastroenterology patients with constipation and associated complaints. 2025.
8.Rybak A, et al. Colonic Function Investigations in Children. J Pediatr Gastroenterol Nutr. 2022.
9.Radiopaedia. Dolichocolon – Radiology Reference Article. Updated 2021.
10.Erkel D, et al. Assessing fecal load with ultrasound in children with constipation. Pediatr Surg Int. 2024.
11.Усмонов ТЮ, Тошпулатов Б. ИММУНОЛОГИЧЕСКИЕ ИЗМЕНЕНИЯ У ДЕТЕЙ С ХРОНИЧЕСКИМИ ЗАПОРАМИ, ВЛИЯНИЕ ХИРУРГИЧЕСКОГО ЛЕЧЕНИЯ. International innovation and researches. 2025 Mar 28;2(2):109-11.
12.Тошпулатов ББ, Туланова ОС. СОВРЕМЕННЫЕ ПОДХОДЫ К ДИАГНОСТИКЕ И ЛЕЧЕНИЮ БОЛЕЗНИ ГИРШПРУНГА У ДЕТЕЙ. International innovation and researches. 2025 Mar 28;2(2):104-5.
13.Тошпулатов ББ, Урмонова РФ. БОЛЕЗНЬ ДОЛИХОСИГМА У ДЕТЕЙ. International innovation and researches. 2025 Mar 28;2(2):112-3.
14.Тошпулатов ББ, Кенжаева Г. ПРИЧИНА ВЫСОКОЙ СМЕРТНОСТИ ПРИ ВРОЖДЕННОЙ ДИАФРАГМАЛЬНОЙ ГРЫЖЕ И ПУТИ ЕЁ СНИЖЕНИЯ. International innovation and researches. 2025 Mar 28;2(2):106-8.
15.Тошпулатов ББ, Туланова О. НЕПРОИЗВОЛЬНОЕ ВЫДЕЛЕНИЕ ФЕКАЛИЙ ПОСЛЕ ОПЕРАЦИИ ПРИ БОЛЕЗНИ ГИРШПРУНГА, ПАТОГЕНЕЗ, ПРОФИЛАКТИКА И ЛЕЧЕНИЕ. International innovation and researches. 2025 Mar 28;2(2):114-8.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.

Germany
United States of America
Italy
United Kingdom
France
Canada
Uzbekistan
Japan
Republic of Korea
Australia
Spain
Switzerland
Sweden
Netherlands
China
India